These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 25306233)

  • 1. Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures.
    Movérare-Skrtic S; Henning P; Liu X; Nagano K; Saito H; Börjesson AE; Sjögren K; Windahl SH; Farman H; Kindlund B; Engdahl C; Koskela A; Zhang FP; Eriksson EE; Zaman F; Hammarstedt A; Isaksson H; Bally M; Kassem A; Lindholm C; Sandberg O; Aspenberg P; Sävendahl L; Feng JQ; Tuckermann J; Tuukkanen J; Poutanen M; Baron R; Lerner UH; Gori F; Ohlsson C
    Nat Med; 2014 Nov; 20(11):1279-88. PubMed ID: 25306233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
    Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
    Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
    Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
    Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoblast-derived NOTUM reduces cortical bone mass in mice and the
    Movérare-Skrtic S; Nilsson KH; Henning P; Funck-Brentano T; Nethander M; Rivadeneira F; Coletto Nunes G; Koskela A; Tuukkanen J; Tuckermann J; Perret C; Souza PPC; Lerner UH; Ohlsson C
    FASEB J; 2019 Oct; 33(10):11163-11179. PubMed ID: 31307226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner.
    Pellegrini GG; Morales CC; Wallace TC; Plotkin LI; Bellido T
    Nutrients; 2016 Jul; 8(7):. PubMed ID: 27409635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of GSK-3β rescues the impairments in bone formation and mechanical properties associated with fracture healing in osteoblast selective connexin 43 deficient mice.
    Loiselle AE; Lloyd SA; Paul EM; Lewis GS; Donahue HJ
    PLoS One; 2013; 8(11):e81399. PubMed ID: 24260576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
    Amirhosseini M; Madsen RV; Escott KJ; Bostrom MP; Ross FP; Fahlgren A
    J Cell Physiol; 2018 Mar; 233(3):2398-2408. PubMed ID: 28731198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.
    Kalyanaraman H; Ramdani G; Joshua J; Schall N; Boss GR; Cory E; Sah RL; Casteel DE; Pilz RB
    J Bone Miner Res; 2017 Jan; 32(1):46-59. PubMed ID: 27391172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt16 regulates osteoclast differentiation in conjunction with Wnt5a.
    Kobayashi Y; Thirukonda GJ; Nakamura Y; Koide M; Yamashita T; Uehara S; Kato H; Udagawa N; Takahashi N
    Biochem Biophys Res Commun; 2015 Aug; 463(4):1278-83. PubMed ID: 26093292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteocyte- and late osteoblast-derived NOTUM reduces cortical bone mass in mice.
    Nilsson KH; Henning P; El Shahawy M; Wu J; Koskela A; Tuukkanen J; Perret C; Lerner UH; Ohlsson C; Movérare-Skrtic S
    Am J Physiol Endocrinol Metab; 2021 May; 320(5):E967-E975. PubMed ID: 33749332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease.
    Stalvey MS; Clines KL; Havasi V; McKibbin CR; Dunn LK; Chung WJ; Clines GA
    PLoS One; 2013; 8(11):e80098. PubMed ID: 24236172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible
    Ohlsson C; Henning P; Nilsson KH; Wu J; Gustafsson KL; Sjögren K; Törnqvist A; Koskela A; Zhang FP; Lagerquist MK; Poutanen M; Tuukkanen J; Lerner UH; Movérare-Skrtic S
    J Endocrinol; 2018 May; 237(2):113-122. PubMed ID: 29530924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malt1 deficient mice develop osteoporosis independent of osteoclast-intrinsic effects of Malt1 deficiency.
    Monajemi M; Fisk S; Pang YCF; Leung J; Menzies SC; Ben-Othman R; Cai B; Kollmann TR; Rozmus J; Sly LM
    J Leukoc Biol; 2019 Oct; 106(4):863-877. PubMed ID: 31313375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes.
    Allison H; Holdsworth G; McNamara LM
    BMC Mol Cell Biol; 2020 Nov; 21(1):78. PubMed ID: 33148174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.
    Maeda K; Kobayashi Y; Udagawa N; Uehara S; Ishihara A; Mizoguchi T; Kikuchi Y; Takada I; Kato S; Kani S; Nishita M; Marumo K; Martin TJ; Minami Y; Takahashi N
    Nat Med; 2012 Feb; 18(3):405-12. PubMed ID: 22344299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone.
    Takyar FM; Tonna S; Ho PW; Crimeen-Irwin B; Baker EK; Martin TJ; Sims NA
    J Bone Miner Res; 2013 Apr; 28(4):912-25. PubMed ID: 23165727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Androgens on Murine Cortical Bone Do Not Require AR or ERα Signaling in Osteoblasts and Osteoclasts.
    Ucer S; Iyer S; Bartell SM; Martin-Millan M; Han L; Kim HN; Weinstein RS; Jilka RL; O'Brien CA; Almeida M; Manolagas SC
    J Bone Miner Res; 2015 Jul; 30(7):1138-49. PubMed ID: 25704845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-selectin ligand 1 regulates bone remodeling by limiting bioactive TGF-β in the bone microenvironment.
    Yang T; Grafe I; Bae Y; Chen S; Chen Y; Bertin TK; Jiang MM; Ambrose CG; Lee B
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7336-41. PubMed ID: 23589896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.